A Day Late And A Dollar Short: Zepto Fixes Unit Economics, But What About Profitability?
Earlier this week, Zepto filed its updated draft red herring prospectus (UDRHP) with the market regulator SEBI. The startup intends to raise ₹8,010 Cr via a fresh issue. The IPO will comprise an offer for sale (OFS) of up to 11.35 Cr shares.
Worth a read for markets-focused operators. Published by Inc42 — context above is the source's own framing.
Earlier this week, Zepto filed its updated draft red herring prospectus (UDRHP) with the market regulator SEBI. The startup intends to raise ₹8,010 Cr via a fresh issue. The IPO will comprise an offer for sale (OFS) of up to 11.35 Cr shares.
This article lives at Inc42. We linked it because we found it valuable for F&B operators.
Contributor
Curated industry coverage by the Restronomics editorial team. Each article is selected from approved F&B publications and includes a Restronomics editor take.
Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bid
Rating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun Pharma's proposed acquisition of US-based Organon & Co.
Restaurant Industry Intelligence
Data-driven insights, trends, and analysis for food & beverage professionals.
Subscribe Free